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Summary Carcinogen-treated rats develop foci of aberrant crypts in the colon (ACFs) that have been
interpreted as preneoplastic lesions. To characterise ACFs further, we studied in the unsectioned colon of rats
the number, multiplicity, some morphological characteristics and the type of mucin production in ACFs. In
ACFs observed 115 days after the administration of 50 mg kg-' 1,2-dimethylhydrazine (DMH), crypt multip-
licity [number of aberrant crypts (AC) per focus] was positively correlated (P<0.0001) with the reduction of
goblet cells, and with luminal and nuclear alterations in the cells surrounding the lumen of the ACs. We
studied mucin production in the unsectioned colon, demonstrating that ACFs producing sulphomucins (like
the normal distal rat colon) were progressively reduced when ACF multiplicity increased, whereas ACFs
containing sialomucins (correlated with an increased risk of colon cancer) or both sulphomucins and
sialomucins increased with crypt multiplicity. We also studied ACFs in the colon and the occurrence of
intestinal tumours in rats treated with azoxymethane (AOM; 64 mg kg-'). A significant association was found
(P = 0.04) between tumours and the presence of 'large' ACFs (AC/ACF> 14 crypts) and a borderline
significant association (P = 0.057) between the presence of tumours and sialomucin-producing ACFs. We
found no association between the number of ACFs, ACF multiplicity and the presence of tumours.
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Data from experimental animals and humans indicate that
colon carcinogenesis is a multistep process in which subse-
quent preneoplastic lesions accumulate in some mucosa cells,
leading finally to neoplastic transformation (Day, 1984; Mor-
son et al., 1992).
Recently, it has been reported that in the colon of rodents
treated with specific colon carcinogens, single aberrant crypts
(AC) or foci of aberrant crypts (ACFs) can be visualised at
low magnification in the unsectioned colon stained with
methylene blue (Bird, 1987). ACFs have also been described
in the resected colonic mucosa of humans at high risk for
colon cancer (Pretlow et al., 1991; Roncucci et al., 1991a),
where they were interpreted as preneoplastic lesions.
The study ofpreneoplastic lesions is very important since it
allows investigations of the stepwise process leading to
cancer. Moreover, preneoplastic lesions can be usesd as end
points in studies of experiments carcinogenesis and as early
risk indicators for humans. However, since the first descrip-
tion of ACFs in the literature (Bird, 1987), some researchers
have wondered whether ACFs may truly be considered
preneoplastic lesions and they have tried to identify dysplas-
tic characteristics (such as nuclear alterations and abnormal
luminal structure) or molecular abnormalities (such as activa-
tion of some oncogenes) in ACFs (McLellan et al., 1991a,b;
Roncucci et al., 1991b; Stopera and Bird, 1992; Stopera et
al., 1992; Vivona et al., 1993). The results of these studies
indicate that some ACFs are indeed dysplastic lesions. How-
ever, only a limited number of ACFs have been evaluated in
the previous studies, and it is not yet clear whether all the
ACFs that are observed in the methylene blue-stained colon
possess dysplastic features. Nor is it clear whether ACFs can
be considered a reliable end point in experimental colon
carcinogenesis (Hardman et al., 1991; Bird and Pretlow,
1992; Dolara and Caderni, 1992).
In fact, to use ACFs as predictor of cancer frequency in
treated animals, different methods have been adopted to
define the characteristics of ACFs to be correlated with
carcinogenesis. In some studies the total number of ACFs or
ACF crypt multiplicity have been used; in some others the
numbers of 'large' ACFs were considered (Corpet et al.,
1990; Pretlow et al., 1992; Zhang et al., 1992; Magnuson et
al., 1993). Although in most studies large ACFs are con-
sidered an indication of rapid growth, no consensus has thus
far been reached on the most appropriate method of relating
ACFs to carcinogenesis.
To characterise further the pathology of ACFs and its
correlation with carcinogenesis, we decided to study ACFs in
the unsectioned colon of rats at different times after 1,2-
dimethylhydrazine (DMH) or azoxymethane (AOM) admin-
istration. Accordingly, we determined in ACFs induced by
these two carcinogens the number, multiplicity and some
morphological alterations such as an abnormal luminal pat-
tern, the reduction in goblet cells and the nuclear alteration
in the cells surrounding the aberrant crypts. We were also
interested in studying mucin production in ACFs observed in
unsectioned colons. Previous investigations performed in his-
tological sections have shown that apparently normal colonic
mucosa from patients with colon cancer and dysplastic foci
observed in the distal colon of carcinogen-treated rats (Filipe
and Branfoot, 1974; Filipe, 1975; Wargovich et al., 1983;
Sandforth et al., 1988) produce predominantly sialomucins
instead of sulphomucins as the normal mucosa.
Materials and methods
Induction ofACFs by DMH and AOM
ACFs were induced with two different experimental pro-
tocols. In the first we used 8- to 9-week-old female
Sprague-Dawley rats (Morini, Italy). Animals were fed a
diet based on the AIN 76 diet (American Institute of Nutri-
tion, 1977), modified to contain a relatively high amount of
fat (23% corn oil), 23% sucrose and 23% starch as source of
carbohydrates (Caderni et al., 1991). The rats were treated
twice p.o., 4 days apart, either with saline or with DMH
(Sigma Chimica, Milan, Italy) at a dose of 25 mg kg-' body
weight (total dose 50 mg kg-'). Forty and 115 days after the
first treatment with DMH the animals were sacrificed by
decapitation under a light ether anaesthesia. Each group was
composed of 16 saline-treated and 16 DMH-treated rats.
In the second protocol we used male Sprague-Dawley rats
(4-5 weeks old), fed a diet of the same composition as
Correspondence: G Caderni
Received 21 July 1994; revised 31 October 1994; accepted 22
November 1994.Aberrant cryptfoci and intestinal carcinogenesis
G Caderni etal
described above. One week after the beginning of the experi-
mental diet rats were treated s.c. with AOM (Sigma Chimica)
at a weekly dose of 8 mg kg-' body weight for 8 weeks (total
dose 64 mg kg-'). We had 60 AOM-treated and 15 saline-
treated rats. Between 158 and 162 days after the first dose of
AOM the animals were sacrificed by decapitation and ACFs
and intestinal tumours were studied. Cancer histological
types were evaluated on the basis of histotype, grading and
pattern of growth according to Morson et al. (1992).
In all the experiments rats were maintained at a constant
environmental temperature of 22°C, with a 12 h light-dark
cycle, according to internationally accepted ethical guidelines
for the treatment of experimental animals (European Com-
munity, 1986).
Determination ofthe number, multiplicity andmorphological
alterations ofACFs
To visualise the ACFs induced by DMH or AOM
treatments, we stained the unsectioned colon with methylene
blue according to Bird (1987). For each rat we determined
the number ofACFs in the entire colon and their multiplicity
by counting the number of ACs forming each focus (AC/
ACF).
Moreover, in the colon of the rats sacrificed 115 days after
DMH, 20 ACFs were randomly chosen from each rat and
evaluated for the following architectural and cytological
characteristics: pattern of luminal outline of the ACs (refer-
red to as 'luminal alteration'), nuclear alteration with
appearance of pseudostratification of the nuclei in the cells
surrounding the lumen (referred to as 'nuclear alteration')
and reduction in the number of goblet cells. This evaluation
was carried out on unsectioned colons stained with
methylene blue (magnification 40-100 x). To evaluate the
luminal alteration of the ACs, each AC was graded as mildly
altered if the luminal outline was enlarged and round,
moderately altered if elliptical or severely altered if slit-like,
irregular and cribriform. In the cytological analysis of the
nuclear alteration each AC was graded as mildly, moderately
or severely altered depending on whether the nuclei, which in
normal cells constitute a single layer close to the bases of the
cells, seemed to occupy less than 35%, 35-50% or more
than 50% of the cell space (epithelium) respectively. In the
analysis of the reduction of goblet cells each AC was graded
as mildly, moderately or severely altered depending on
whether the reduction in the number of goblet cells was,
respectively, less than 10%, 10-50% or more than 50%
compared with those surrounding the normal crypts. To each
grade of morphological alteration we arbitrarily attributed
the value of 1, 2 or 3 (for mild, moderate and severe altera-
tion respectively). Finally, the overall grade of ACF altera-
tion was calculated by summing these values for each AC
forming the focus and then dividing this value by the number
of ACs in that focus.
Determination ofmucusproduction in the ACFs
After the determination of the number of multiplicity of the
ACFs using the methylene blue staining method, the colons
were kept in buffered formalin and later processed with the
high-iron diamine Alcian blue (HID-AB) procedure for the
analysis of mucus production (Filipe, 1975). Briefly, the
entire colon was rinsed for 5 min in distilled water and then
transferred into a Petri dish containing a freshly prepared
solution, referred to as diamine solution, obtained by dissolv-
ing simultaneously 120 mg of N-N'-dimethyl-m-phenylene
diamine and 20mg of N-N'-dimethyl-p-phenylene diamine
(Sigma Chimica) in 50 ml of distilled water and then adding
1.4 ml of 60% ferric chloride. The Petri dish was covered
with aluminium foil for protection against the light and the
colon was stained by the diamine solution for 18 h at room
temperature. The colon was then rinsed three times in dis-
tilled water and stained for 30 min with a solution of 1%
Alcian blue (Sigma Chimica) in 3% acetic acid. The colon
was then rinsed three times with 80% ethanol followed by
distilled water and observed under the microscope with the
mucosal side up at a magnification of 40 x. As a result of
this procedure the cells surrounding the opening of the crypts
in the distal part of the colon were stained dark brown,
indicating a predominance of sulphomucin secretion. Moving
from the distal to the proximal part of the colon the cells
surrounding the opening of the crypts became increasingly
blue, indicating a predominance of sialomucin secretion. This
shift from sulphomucin to sialomucin production along the
length of the rat colon, going towards the proximal part, has
been previously described in histological sections (Filipe,
1975).
We examined only the distal part of the rat colons since
the distal colon shows a pattern of mucus production similar
to that of the normal human colorectal mucosa in which
sulphomucin secretion predominates and since precancerous
alterations in the human and distal rat colon are accom-
panied by a shift from sulphomucin to sialomucin secretion
(Filipe and Branfoot, 1974; Filipe, 1975). The examination of
DMH-treated rats showed that after the HID-AB procedure
the ACFs were stained either dark brown, like the normal
surrounding crypts (in which sulphomucin production
predominates), or blue (in which sialomucin production
predominates; Figure la), or both brown and blue together
Figure 1 Distal colon of a rat 115 days after treatment with
DMH, stained with the HID-AB technique as described in
Materials and methods. (a) A blue ACF secreting sialomucins is
surrounded by normal crypts producing sulphomucins (dark
brown). (b) An ACF producing both sulpho- and sialomucins
(blue-brown) is surrounded by normal sulphomucin-producing
crypts (magnification 100 x).
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764(in which sulphomucins and sialomucins were present
together; Figure lb). The dark-brown ACFs were easily dis-
tinguished from the normal crypts, being larger and with a
thicker epithelial lining; the blue and blue-brown ACFs,
besides the morphological characteristics pertaining to these
lesions (Bird, 1987), were easily identified against the back-
ground of normal brown crypts (Figure la and b). The
number of ACFs and their multiplicity (AC/ACF) scored
with the methylene blue and with HID-AB technique were
significantly correlated (r= 0.88 and 0.96 for the number of
ACFs and AC/ACF respectively).
Statistical analysis ofthe data
Differences between means were evaluated using Student's
t-test for unpaired samples; the correlations between the
alterations of the morphological parameters and the multi-
plicity of ACFs were analysed by a linear regression model
using Statgraphics Statistical Package (Statistical Graphic
Corporation, Rockville, MD, USA).
To establish whether an ACF parameter would relate to
tumour incidence in carcinogen-treated rats, we evaluated the
probability of bearing a tumour as a function of each of the
different parameters of ACFs analysed, by means of a logis-
tic regression model in which the binary response was bearing
or not bearing a tumour. For each parameter, the regression
coefficient is an estimate of this association. The odds ratio
(OR) of each parameter is calculated as eregresson coeffcient = OR;
the corresponding 95% confidejce limits (CLs) are obtained
from the model fitting. The association is considered statis-
tically significant when the 95% CLs do not include the value
of 1 (Rothman, 1986).
The association between the distribution of mucin produc-
tion and bearing or not bearing a tumour was evaluated
according to the generalised estimating equation (GEE)
(Liang and Zeger, 1986), which is based on a logistic regres-
sion model. From this analysis we calculated odds ratios
(OR) and the corresponding 95% CLs as described above.
The application of GEE is appropriate when there is a
correlation among observations. In fact, within the same rat,
three measurements were determined: the number of
sulphomucin-producing ACFs, the number of ACFs produc-
ing sulpho- and sialomucins and the number of ACFs pro-
ducing sialomucins. These measurements are correlated with
each other (r = 0.45), in the same rat (cluster). Therefore, the
dependence among observations from the same cluster (rat)
must be accounted for in assessing the relationship between
the different risk factors and tumour outcome.
Results
Characterisation ofACFs 40 and 115 days after DMH
adninistration
We studied ACFs in the colons of rats treated twice, 4 days
apart, with 25 mg kg-' DMH or saline and sacrificed 40 and
115 days after DMH administration. The colon was first
stained with methylene blue as described and the number of
multiplicity of ACFs were determined. The results indicated
that the number ofACFs was similar in the rats sacrificed 40
or 115 days after DMH administration (82.5 ± 13.8 and
85.2 + 10.2, means ± s.e.). As expected, the results also
indicated that the multiplicity of ACFs (number of ACs/
ACF) was lower in rats sacrificed 40 days after DMH
(1.78±0.05) than in rats sacrificed 115 days after (2.92±
0.17, means ± s.e., P<0.001). No ACFs were found in the
colon of saline-treated rats.
We then evaluated 20 ACFs randomly chosen in each rat
sacrificed 115 days after DMH (total number of ACFs
analysed = 313 - 312) for the following morphological char-
acteristics: nuclear alteration in the cells surrounding the
lumen of the ACs, luminal alteration and reduction in the
number of goblet cells as described in Materials and
methods. This evaluation was carried out by observing these
Aberrantcrypt foci and intestinal carcinogenesis
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parameters in the unsectioned colon, since with this topo-
graphical approach it was possible to study more lesions than
in histological sections.
Each AC or ACF was graded as having mild, moderate or
severe alterations as described in the Materials and methods
section. The results indicated (Table I) that most ACs had
mild or moderate alterations and only a few showed severe
nuclear alteration and goblet cell reduction. We also deter-
mined the grades of morphological alterations in ACFs as a
function of their multiplicity (AC/ACF). The results
indicated (Figure 2a-c) that crypt multiplicity was positively
correlated with the severity of all the morphological altera-
tions analysed (luminal alteration, goblet cell reduction and
nuclear alteration in the cells surrounding the lumen of the
crypt).
We also studied the type of mucus produced by the ACFs.
The distal colon ofeach rat treated with DMH and sacrificed
40 and 115 days later was therefore stained with the HID-AB
technique and the number and multipliciiy of the ACFs and
type of mucus secreted were recorded. The results relative to
the rats sacrificed 115 days after DMH (Table II) indicated
that some of the ACFs still retained the sulphomucin secre-
tion typical of the normal mucosa but that most ACFs
secreted both sulpho- and sialomucins. A smaller fraction of
ACFs secreted only sialomucins.
Similarly, 40 days after the carcinogen treatment, most
ACFs secreted sulpho- and sialomucins (data not shown).
We calculated the correlation between the type of mucin
produced by the ACFs and ACF multiplicity. The results
relative to ACFs observed 115 days after DMH indicated
(Figure 2d) that, when ACF multiplicity increased, the
percentage of ACFs producing sulphomucins decreased
rapidly, while the percentage of ACFs containing both sul-
phomucins and sialomucins progressively increased. A few
ACFs composed entirely of sialomucins were also observed
in ACFs formed by few crypts, and their number slowly
increased with the increase in ACF muliplicity. The ACFs
observed in rats sacrificed 40 days after DMH showed a
similar correlation between mucin production and crypt mul-
tiplicity (data not shown).
Characterisation ofACFs determined 160 days after AOM
administration in rats with and without tumours
Rats were treated with 8 mg kg-' AOM weekly for 8 weeks
and sacrificed 158-162 days after the first injection with
AOM. At this time (about 160 days after AOM) we studied
intestinal tumours and ACFs in the colon. The results of
histopathological examination of the whole intestine (Table
III) indicated that the majority of tumours (both adenocar-
cinomas and adenomas) were induced in the colon, and only
a few were found in the small intestine. The control rats
treated with saline did not develop tumours.
Since we were interested in studying the ACFs also when
tumours were evident, after excision of the tumours for
histopathology, the whole colon, fixed in buffered formalin,
was stained with methylene blue in order to determine the
number and crypt multiplicity of the ACFs. The results of
this study indicated that ACFs per colon were 234 ± 32 and
that their multiplicity (AC/ACF) was 2.53 ± 0.09 (means ±
s.e.). In the control rats only one animal developed four
ACFs, with multiplicity (AC/ACF) = 3. No ACFs were
found in the other saline-treated rats.
Table I Distribution ofdifferent gradesofmorphological alteration in
ACs in the colon of rats 115 days after DMH treatment
Parameter Mild Moderate Severe
Nuclear alteration' 74 (651) 25.8 (227) 0.2 (2)
Luminal alterationa 37.5 (328) 62.5 (546) 0 (0)
Goblet cell reductiona 64.6 (567) 34.5 (303) 0.9 (8)
aValues represent thepercentage ofACs overtotal ACs ineach grade
of morphological alteration. The absolute number of ACs is given in
parentheses.Aberntcryptfod and intesinal card_nonesis
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Figure 2 (a-c) Correlation between ACF multiplicity (AC/ACF) and individual values of morphological alteration graded with
arbitrary values from 1 to 3 according to progressively severe morphological alterations of the AC forming a focus. The
morphological characteristics analysed were (a) luminal alterations (number of ACFs analysed n = 312); (b) reduction in the
number of goblet cells (n = 313); (c) nuclear alterations (n = 313). Given the large number of ACFs studied, it was impossible to
draw all the experimental points in the figure. Therefore, circles with different diameters have been drawn proportional to the
different number of ACFs that they represent. The filled circles represent points for which only one ACF has been found. In each
panel Qn = 50 gives a graphical representation of this number of observations. (d) Distribution of the ACF multiplicity in the
distal colon according to the type of mucus produced by the ACF. For each value of ACF multiplicity (AC/ACF) we calculated
the percentage of ACF/total ACFs secreting sulphomucins (-C-), sulphomucins and sialomucins together (---) and sialomucins
(-A-).
Table II Mucin productiona in ACFsobserved in thecolon ofrats 115
days after DMH treatment
Sulphomucins Sulpho-sialomucins Sialomucins
26.6 (363) 58.4 (796) 15 (205)
aValues represent the percentage of ACFs over total ACFs in each
category ofmucus secretion. The absolute number ofACFs counted is
given in parentheses.
The distal part of the colons was also stained with the
HID-AB technique to determine mucin production. We
found that the distribution of ACFs secreting different types
of mucins was similar to that observed in the DMH
experiments. In fact, we found that 34% of ACFs secreted
sulphomucins, 55.3% a mixture of sulpho- and sialomucins
and 10.4% of ACFs secreted only sialomucins.
Since we wanted to evaluate which characteristics of ACFs
would related to tumour occurrence in the treated rats, we
determined the number and multiplicity of the ACFs and the
type of mucin produced in tumour-bearing and tumour-free
rats. We also examined whether the probability of bearing a
tumour was associated with each of the different ACF
parameters analysed, calculating odds ratios (OR) as a
measure of this association and the corresponding 95% CLs
Table In Tumour outcome in rats treated with multiple injections of
AOM (total dose 64mg kg-')
Colonic adenocarcinomas per rata 0.55 ± 0.11
Colonic adenomas per rata 0.59 ± 0.15
Small intestinal adenocarcinomas per rata 0.11 ± 0.04
Small intestinal adenomas per rata 0.02 ± 0.02
Frequency of total intestinal tumoursb 64.6%
aThe values are the mean number of each type of tumour per
rat ± s.e., n = 54. "The value represents the percentage of rats with
intestinal (colonic and small intestinal) tumours (adenomas and
adenocarcinomas).
with a logistic regression model as explained in detail in the
Materials and methods section.
As illustrated in Figure 3a, the animals which developed
tumours tended to have more ACFs than tumour-free rats;
analysis of these results with the logistic model indicated that
the probability of developing tumours is not statistically
associated with the number of ACFs per colon (OR = 1.003,
95% CLs = 0.996-1.008). Crypt multiplicity (Figure 3b) was
similar in rats with or without tumours (OR = 0.57, 95%
CLs = 0.12-2.64).
Since it has been suggested that the number of 'large'
ACFs could be used to predict colon carcinogenesis in
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Figure 3 Some ACF parameters in tumour-bearing (-) and in
tumour-free rats (0). (a) Number of ACFs per colon. (b) ACF
multiplicity (AC/ACF). (c) Number of ACFs per colon equal to
or larger than 14 AC/ACF. *P<0.05 compared with the
tumour-bearing rats. Values are means ± s.e.; n = 26 and 12 in
tumour-bearing and tumour-free rats respectively.
rodents treated with carcinogens (Corpet et al., 1990; Pretlow
et al., 1992; Zhang et al., 1992), we also evaluated this
parameter in tumour-bearing and tumour-free rats. We
defined 'large' ACFs according to Corpet et al. (1990) as
being of such a size that at least one large ACF per rat was
present. Using this criterion, 'large' ACFs in our AOM
experiment were those formed by 14 or more crypts. The
results obtained (Figure 3c) showed that the number of large
ACFs in the rats which developed tumours was significantly
higher than in tumour-free rats; the analysis relative to the
probability of bearing a tumour as a function of the presence
of a high number of large ACFs showed a significant associa-
tion between the presence of a tumour and number of large
ACFs: OR = 3.30 with 95% CLs = 1.1 - 10.2. On the other
hand, defining 'large ACFs' according to Zhang et al. (1992)
(in our AOM experiment ACFs formed by ten or more
Table IV Distribution ofACFs secreting different types ofmucins in
AOM-treated rats both with tumours and tumour-free
Sulphomucins Sulpho-sialomucins Sialomucins
Tumour-bearing rats 34.7 (931) 53.2 (1430) 12.1 (325)
Tumour-free rats 33.2 (397) 60 (717) 6.7 (80)a
aValues represent the percentage of ACFs over total ACFs. The
absolute number ofACFs found in each category ofmucus secretion is
given in parentheses. aThe differences between the percentage of
sialomucin-producing ACFs in tumour-bearing and tumour-free rats is
borderline statistically significant (P = 0.057) as determined by
generalised estimatingequationanalysis (seethe Materials andmethods
section for explanation).
crypts), the animals with tumours had a higher number of
large ACFs than tumour-free rats, but the difference was not
statistically significant (large ACFs were 3.38 ± 0.75 and
1.87 ± 0.35 in the tumour-bearing and tumour-free rats
respectively; means ± s.e.).
We also evaluated the type of mucin produced by the
ACFs in tumour-bearing and tumour-free rats. The distribu-
tion of the different types ofmucin produced by the ACFs in
tumour-bearing and in tumour-free rats (Table IV) showed
that in tumour-free rats fewer sialomucins and more mixed
sulpho- and sialomucins were present. The results indicated a
borderline significant association (P = 0.057) between the
presence of sialomucin-producing ACFs and the probability
of bearing a tumour (OR = 2.04 with 95% CLs 1-4.2).
Discussion
In recent years several laboratories have been using ACFs as
an end point in short-term tests for predicting colon car-
cinogenesis in rodents (Tudek et al., 1989; Corpet et al.,
1990; Pretlow et al., 1990; Zhang et al., 1992). ACFs are
easily scored in the unsectioned colon of carcinogen-treated
animals, and they develop as early as 2-4 weeks after car-
cinogen administration. Moreover, the ACF assay requires a
relatively small number of animals and a short experimental
time as compared with long-term carcinogenesis studies.
Therefore this assay has attained considerable popularity as a
short-term test for the study of the modulating effects of
chemicals and/or dietary factors on experimental colon car-
cinogenesis.
Notwithstanding the merits of the ACF assay, the relation-
ship between ACFs and carcinogenesis seems to be rather
complicated. It is certain that colon carcinogens induce ACFs
dose dependently and that the number of ACFs is correlated
with the potency of the carcinogen (Tudek et al., 1993).
However, some authors (Hardman et al., 1991) have not
observed an association between the incidence of colon
cancer and ACF number or size, and most others do not use
the same parameters to describe the association of ACFs
with carcinogenesis. Some authors stress the importance of
ACF multiplicity (AC/ACF) (Magnuson et al., 1993), while
others favour the number of 'large' ACFs, but they calculate
'large' ACFs using different criteria (Corpet et al., 1990;
Pretlow et al., 1992; Zhang et al., 1992).
Given the current undetermined relationship between
ACFs and carcinogenesis, the validity of the ACF assay has
been questioned (Hardman et al., 1991; Magnuson et al.,
1993) and the possibility has been raised that ACFs are
elementary lesions, only a few of which are truly preneoplas-
tic.
Some authors have also studied genetic lesions which occur
in colon adenomas and carcinomas in ACFs. Accordingly, it
has been demonstrated that a small subpopulation of ACFs
have increased expression and activation of the ras oncogene
(Stopera and Bird, 1992; Stopera et al., 1992; Vivona et al.,
1993). Other studies have focused on ACF dysplasia, with
the aim of identifying the actual dysplastic lesions within the
ACF population (McLellan et al., 1991b; Roncucci et al.,
1991b). The limitation of these studies is that only a small
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number of ACFs were analysed and the results were not
studied in association with carcinogenesis.
In the present paper we try to identify and quantify a
series of morphological alterations in ACFs observed in
whole unsectioned colons with the same topographical app-
roach used for the determination of ACFs with the
methylene blue staining technique. We performed two sets of
experiments, one in which ACFs were induced by DMH and
a second one involving AOM, a metabolite of DMH cur-
rently used in colon carcinogenesis studies.
We observed some morphological alterations (nuclear and
luminal alterations and goblet cell reduction) in a relatively
large number of ACFs (about 300).
Usually the evaluation of morphological alterations in a
tissue is carried out on histological sections, in which various
morphological aspects of dysplasia are determined (Morson
et al., 1992). In the present study, we attempted to identify
morphological alterations, similar to those characterising
dysplasia, in unsectioned specimens; in fact, the differential
staining of ACFs with methylene blue is in itself a sign of
altered cellular and tissue structures. The alterations that we
observed in the ACFs are relatively modest, although they
seem to be similar to the dysplastic alterations observed in
histological specimens of adenomas or microadenomas. In
these lesions, the cytoarchitectural alterations and dysplastic
characteristics are usually more evident and severe than those
observed in ACFS, due partially to a larger size of adenomas
or microadenomas. In fact, if the same criteria used to
graduate dysplasia in adenomas are applied to ACFs, the
majority of ACFs would be graded as having mild or
moderate morphological alterations.
We find that luminal alteration, goblet cell reduction and
nuclear alterations of the cells surrounding the lumen of the
crypt are correlated with increased multiplicity of ACFs.
These results suggest that the growth of at least some ACFs
(as assessed by increased ACF multiplicity) is accompanied
by acquisition of dysplastic features typical of precancerous
lesions.
We demonstrate that it is possible to study mucin produc-
tion by ACFs, determining sulpho- and sialomucins in whole
unsectioned distal colons stained with the HID-AB tech-
nique.
We can detect ACFs with the HID-AB technique as well
as with methylene blue staining, as demonstrated by the
highly significant correlation between the number of ACFs
per colon and multiplicity using the two methods. ACFs
secreting only sulphomucins are progressively reduced in
number as crypt multiplicity increases. On the other hand,
ACFs containing both sulpho- and sialomucins progressively
increase as does crypt multiplicity. A progression from sul-
phomucin to sialomucin production has been described in
colon microadenomas and dysplastic foci in histological sec-
tions of the colon of DMH-treated rats, and it has been
suggested that this mucin alteration occurs early in colon
carcinogenesis (Filipe, 1975; Wargovich et al., 1983; Sand-
forth et al., 1988). Therefore, similarly to what is observed
for the morphological alterations, these results suggest that
most ACFs, when growing, tend to lose the characteristics of
normal mucosa, gaining those of preneoplastic lesions.
We attempted to study the association between car-
cinogenesis and ACFs by examining the different parameters
of ACFs in tumour-bearing and tumour-free rats. Therefore,
we evaluated the probability of bearing a tumour as a func-
tion of each of the different parameters of ACFs analysed
using a logistic regression model. The results of this effort
demonstrate, in agreement with previous results (Hardman et
al., 1991; Magnuson et al., 1993), that there is no association
between the total number of ACFs or their multiplicity and
the presence of tumour in the animal. We observed that
tumour-free animals had the same number and multiplicity
of ACFs as those bearing tumours. On the other hand, we
found that the tumour-free rats have significantly fewer
'large' ACFs (> 14 AC/ACF) than tumour-bearing rats and
that the probability of bearing a tumour in relation to the
presence of large ACFs is statistically significant (P= 0.04).
Our results show a borderline significant association
(P = 0.057) between the presence of sialomucin-producing
ACFs and the probability of bearing a tumour, sialomucins
being more represented in the ACFs of tumour-bearing
animals than in those of tumour-free rats.
On the basis of our results, we suggest that the best
parameter for studying the association between carcino-
genesis and ACF is the number of 'large' ACFs and the
presence of sialomucin-producing ACFs.
It is not yet clear if the ACFs that have an abnormal
secretion of sialomucin and large dimensions are the same as
those which accumulate genetic damage relevant for cancer
developement. Most previous genetic studies with this model
were carried out on small populations of ACFs, and the
association between size and expression of genetic damage
was not studied.
It would be useful if protocols could be developed to
screen the ACFs in whole colon with molecular biological
methods. In the meantime an improvement in the perfor-
mance of the ACF assay might be possible, by classifying
ACFs using these two simple morphological parameters
(number of large ACFs and sialomucin production).
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